[go: up one dir, main page]

NO990157D0 - Granulater av heksahydropyrazinderivater som kan bli administrert oralt - Google Patents

Granulater av heksahydropyrazinderivater som kan bli administrert oralt

Info

Publication number
NO990157D0
NO990157D0 NO990157A NO990157A NO990157D0 NO 990157 D0 NO990157 D0 NO 990157D0 NO 990157 A NO990157 A NO 990157A NO 990157 A NO990157 A NO 990157A NO 990157 D0 NO990157 D0 NO 990157D0
Authority
NO
Norway
Prior art keywords
granules
administered orally
hexahydropyrazine derivatives
hexahydropyrazine
derivatives
Prior art date
Application number
NO990157A
Other languages
English (en)
Other versions
NO325272B1 (no
NO990157L (no
Inventor
Jochen Kalbe
Terence Hopkins
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO990157L publication Critical patent/NO990157L/no
Publication of NO990157D0 publication Critical patent/NO990157D0/no
Publication of NO325272B1 publication Critical patent/NO325272B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19990157A 1996-07-17 1999-01-14 Fremgangsmate for fremstilling av oralt administrerbare formuleringer av heksahydropyrazinderivater samt granulater inneholdende slike derivater NO325272B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19628776A DE19628776A1 (de) 1996-07-17 1996-07-17 Oral applizierbare Granulate von Hexahydropyrazinderivaten
PCT/EP1997/003537 WO1998003157A1 (de) 1996-07-17 1997-07-04 Oral applizierbare granulate von hexahydropyrazinderivaten

Publications (3)

Publication Number Publication Date
NO990157L NO990157L (no) 1999-01-14
NO990157D0 true NO990157D0 (no) 1999-01-14
NO325272B1 NO325272B1 (no) 2008-03-17

Family

ID=7800044

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990157A NO325272B1 (no) 1996-07-17 1999-01-14 Fremgangsmate for fremstilling av oralt administrerbare formuleringer av heksahydropyrazinderivater samt granulater inneholdende slike derivater

Country Status (17)

Country Link
US (1) US6503536B2 (no)
EP (1) EP0912167B1 (no)
JP (1) JP4202422B2 (no)
KR (1) KR100485149B1 (no)
CN (1) CN1225579A (no)
AT (1) ATE227565T1 (no)
AU (1) AU711705B2 (no)
BR (1) BR9710377B1 (no)
CA (1) CA2260889C (no)
DE (2) DE19628776A1 (no)
DK (1) DK0912167T3 (no)
ES (1) ES2183200T3 (no)
HU (1) HUP9903180A3 (no)
NO (1) NO325272B1 (no)
NZ (1) NZ333745A (no)
PT (1) PT912167E (no)
WO (1) WO1998003157A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003262643A1 (en) * 2002-08-13 2004-02-25 Intervet International B.V. Compositions and process for delivering an additive
US20040180034A1 (en) * 2003-03-10 2004-09-16 Lyn Hughes Anthelmintic resinates and a method for their preparation
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
US7582612B2 (en) * 2004-03-12 2009-09-01 Hartz Mountain Corporation Multi-action anthelmintic formulations
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
SI2811998T1 (sl) 2012-02-06 2019-02-28 Merial, Inc. Paraziticidni peroralni veterinarski sestavki, ki obsegajo sistemsko delujoče učinkovine, postopki in njihove uporabe
NZ631100A (en) 2012-04-04 2016-06-24 Intervet Int Bv Soft chewable pharmaceutical products

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
EP0134984B1 (en) 1983-07-16 1988-07-13 Beecham Group Plc Benzazepine and benzoxazepine derivatives
DE3623321A1 (de) * 1986-07-11 1988-01-21 Bayer Ag Verfahren zur kontinuierlichen herstellung von sphaerischen granulaten
FI101344B (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
CN1099973A (zh) * 1993-09-08 1995-03-15 四川省医学科学院寄生虫病防治研究所 兽用驱虫药物复方制剂
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations

Also Published As

Publication number Publication date
CA2260889A1 (en) 1998-01-29
KR20000067862A (ko) 2000-11-25
BR9710377A (pt) 1999-08-17
NZ333745A (en) 2000-10-27
JP2000515519A (ja) 2000-11-21
CN1225579A (zh) 1999-08-11
US20010055598A1 (en) 2001-12-27
DE19628776A1 (de) 1998-01-22
BR9710377B1 (pt) 2011-10-18
DE59708723D1 (de) 2002-12-19
AU3541397A (en) 1998-02-10
NO325272B1 (no) 2008-03-17
NO990157L (no) 1999-01-14
HUP9903180A3 (en) 2000-07-28
KR100485149B1 (ko) 2005-04-25
DK0912167T3 (da) 2003-03-10
JP4202422B2 (ja) 2008-12-24
EP0912167A1 (de) 1999-05-06
PT912167E (pt) 2003-03-31
ATE227565T1 (de) 2002-11-15
EP0912167B1 (de) 2002-11-13
HUP9903180A2 (hu) 2000-04-28
CA2260889C (en) 2007-09-11
AU711705B2 (en) 1999-10-21
ES2183200T3 (es) 2003-03-16
US6503536B2 (en) 2003-01-07
WO1998003157A1 (de) 1998-01-29

Similar Documents

Publication Publication Date Title
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
NO933028D0 (no) Peg-interferonkonjugater
CA2258217A1 (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
NO990157D0 (no) Granulater av heksahydropyrazinderivater som kan bli administrert oralt
MY117606A (en) Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids
DK0736033T3 (da) Hidtil ukendte terapeutiske carbohydratblandinger, som er nyttige til afhjælpning af præmenstruelt syndrom
KR910018381A (ko) 개선된 에르골린-8-카복스아미드
PT1091740E (pt) Preparacoes aquosas semi-solidas para administracao oral de toltrazuril-sulfona
NO975127L (no) Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater
DK1202956T3 (da) Terapeutisk og/eller ernærngsmæssigt forstærkede derivater af aktive bestanddele og oralt indgivelsesbare præparater indeholdende de samme
BR0107630A (pt) Composição
IL67686A (en) 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them
AU6725300A (en) Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
KR910000645A (ko) 개선된 경련치료제
KR910009723A (ko) 4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
JPS5359095A (en) Preparation of 7-aminocephem cpds.
DK0488044T3 (da) En imidazobenzodiazepin til behandling af søvnforstyrrelser
JPS5325534A (en) Mandelic acid glucosides and their anti-cancerous preparations
RU99118372A (ru) Антиоксидантная композиция
JPS5325558A (en) Novel pyrrole derivatives and their preparation
JPS5367795A (en) Preparation of microhydrogel
JPS56110622A (en) Carcinostatic agent

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MM1K Lapsed by not paying the annual fees